Financial reports
10-K
2023 FY
Annual report
29 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
1 Aug 23
10-Q
2023 Q1
Quarterly report
2 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
1 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
3 May 22
10-K
2021 FY
Annual report
1 Mar 22
Current reports
8-K
Entry into a Material Definitive Agreement
16 Apr 24
8-K
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
1 Apr 24
8-K
Entry into a Material Definitive Agreement
29 Feb 24
8-K
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
22 Feb 24
8-K
Regulation FD Disclosure
4 Jan 24
8-K
Entry into a Material Definitive Agreement
4 Jan 24
8-K
Amendments to Articles of Incorporation or Bylaws
18 Dec 23
8-K
Other Events
6 Dec 23
8-K
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
7 Nov 23
8-K
Other Events
21 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
29 Feb 24
424B5
Prospectus supplement for primary offering
29 Feb 24
S-3ASR
Automatic shelf registration
2 Mar 23
S-8
Registration of securities for employees
2 Mar 23
424B5
Prospectus supplement for primary offering
15 Sep 22
424B5
Prospectus supplement for primary offering
14 Sep 22
S-8
Registration of securities for employees
1 Mar 22
S-8
Registration of securities for employees
1 Mar 22
S-3
Shelf registration
2 Nov 21
S-8
Registration of securities for employees
1 Mar 21
Proxies
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEF 14A
Definitive proxy
27 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
DEFA14A
Additional proxy soliciting materials
27 Apr 21
DEF 14A
Definitive proxy
27 Apr 21
DEFA14A
Additional proxy soliciting materials
29 Apr 20
DEF 14A
Definitive proxy
29 Apr 20
DEF 14A
Definitive proxy
30 Apr 19
DEF 14A
Definitive proxy
30 Apr 18
Other
EFFECT
Notice of effectiveness
16 Nov 21
CORRESP
Correspondence with SEC
10 Nov 21
UPLOAD
Letter from SEC
9 Nov 21
CT ORDER
Confidential treatment order
17 Aug 20
EFFECT
Notice of effectiveness
21 Jun 18
CORRESP
Correspondence with SEC
18 Jun 18
UPLOAD
Letter from SEC
18 Jun 18
CORRESP
Correspondence with SEC
18 Jun 18
CT ORDER
Confidential treatment order
5 Jun 18
CT ORDER
Confidential treatment order
5 Oct 17
Ownership
SC 13D/A
PERCEPTIVE ADVISORS LLC
17 Apr 24
4
Yann Mazabraud
16 Apr 24
4
Christopher Paul German
3 Apr 24
SC 13D/A
PERCEPTIVE ADVISORS LLC
3 Apr 24
4
Joseph Shulman
22 Mar 24
4
Jennifer Kayden Lee
22 Mar 24
144
Notice of proposed sale of securities
21 Mar 24
SC 13D
PERCEPTIVE ADVISORS LLC
20 Mar 24
144
Notice of proposed sale of securities
20 Mar 24
4
Hunter C Smith
19 Mar 24